Envoy Medical Inc

Envoy Medical Inc(COCH)股票分析

$7.220

+0.122 (+1.69%)收盘时

Loading chart…
最高
7.240
开盘
7.050
成交量加权均价
7.12
成交量
50.47K
市值
44.88M
最低
6.900
成交额
359.37K
企业价值/息税折旧摊销前利润(TTM)
-1.23

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

AI 分析 of Envoy Medical Inc (COCH)

买入

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

估值指标

Envoy Medical Inc(COCH)当前预期市盈率为 0.00,5 年平均预期市盈率为 -1.83。

预期市盈率

高估
5 年均值 P/E
-1.83
当前P/E
0.00
高估
-0.18
低估
-3.47

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-1.22
当前EV/EBITDA
-1.23
高估
0.67
低估
-3.10

预期市销率

合理
5 年均值 P/S
113.45
当前P/S
201.61
高估
203.65
低估
23.26

Alphio AI 对 COCH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%COCH

$1.15

情景价格

基

基准

基准 · 50%COCH

$1.10

情景价格

悲

悲观

悲观 · 25%COCH

$1.10

情景价格

事件时间线

2026-10-26 (ET)

10:00:00

Envoy Medical Inc Trading Halted

2026-10-23 (ET)

20:00:00

Envoy Medical Inc Trading Halted, News Pending

2026-06-02 (ET)

08:50:00

Envoy Medical Signs Media Deal with New to The Street

2025-12-18 (ET)

17:30:00

Envoy Medical Files to Sell Class A Common Stock

2024-11-14 (ET)

07:42:28

Envoy Medical reports Q3 EPS (37c) vs. 13c last year.

资讯

COCH 常见问题 —— 由 Alphio AI 解答

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Envoy Medical Inc is a good buy right now due to its recent performance and positive outlook. The current price is $6.65, which is significantly below the analyst price targets of $2.00 and $2.50, indicating a potential upside. Additionally, the stock has shown a remarkable year-to-date change of +855.87% and a 20-day change of +921.51%, reflecting strong momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.70 for the upcoming earnings report, which could impact investor sentiment.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易